Full Press Release Details
Press Releases
Video Library
Careers
SUO 2024 TOPLINE RESULTS FROM BOND-003
by
admin
Dec 9, 2024
congress-hub-presentations
CGON Neutral Sentiment
SUO 2024 TOPLINE RESULTS FROM BOND-003
Key Takeaway: The article announces the topline results from the BOND-003 study, which is part of the SUO 2024 conference. Further details regarding the findings and implications of the study are not provided in the text. The announcement is made by the admin on December 9, 2024.
Price reaction · baseline $34.02 (2024-12-09T17:25:00.000Z) · hit during market hours · clean, no other CGON news in the window
day 0 close · peak
-2.3%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+139%
120-day peak, hindsight
Typical move
6.3%
average across 5 past catalysts
Cash runway
~66 mo
Minimal dilution risk
Lead asset
CG0070
Phase 2 · Non Muscle Invasive Bladder Cancer